TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35064689

Group type: EXPERIMENTAL
Intervention: Tactile graphic book with audio and teacher supervision (ATB/TS) group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Audio/hands-on (A/HO) group
Number of subjects: 40
Study: 33030584

Group type: EXPERIMENTAL
Intervention: Ankylosing spondylitis (AS) group
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 104
Study: 35030476

Group type: EXPERIMENTAL
Intervention: MTHFR gene polymorphism (rs2274976)
Number of subjects: 168

Group type: COMPARATOR
Intervention: AGT gene polymorphism (rs699)
Number of subjects: 168

Group type: COMPARATOR
Intervention: VEGF gene polymorphism (rs3025035)
Number of subjects: 168

Group type: COMPARATOR
Intervention: VEGF gene polymorphism (rs3024987)
Number of subjects: 168

Group type: COMPARATOR
Intervention: VEGF gene polymorphism (rs3025039)
Number of subjects: 168
Study: 32351164

Group type: EXPERIMENTAL
Intervention: Ublituximab (150 mg over 1–4 hours on day 1 and 450–600 mg over 1–3 hours on day 15 and week 24)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ublituximab
Number of subjects: 48
Study: 33241542

Group type: EXPERIMENTAL
Intervention: Isometric quadriceps exercise with auditory and visual feedback
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standardized program for TKA
Number of subjects: 62
Study: 33836810

Group type: EXPERIMENTAL
Intervention: Unaccompanied course (no support from psychologist via weekly phone calls)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Accompanied course (support from a psychologist via weekly phone calls)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Waiting list control group (access to the intervention after 24 weeks)
Number of subjects: 400
Study: 32743950

Group type: EXPERIMENTAL
Intervention: Pain Buddy intervention group (N = 20)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Attention control group (N = 28)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48
Study: 36484872

Group type: EXPERIMENTAL
Intervention: Synbiotic capsule containing 6 × 10^9 CFU Lactobacillus coagulans SC‐208, 6 × 10^9 CFU Lactobacillus indicus HU36 and fructooligosaccharide as a prebiotic, taken twice a day for eight weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo, taken twice a day for eight weeks
Number of subjects: 60
Study: 33565694

Group type: EXPERIMENTAL
Intervention: Numerical descriptor only (4% alcohol by volume (ABV))
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Combined verbal and numerical descriptor (Super Low 4%ABV)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Verbal descriptor only (Super Low)
Number of subjects: 147
Study: 33771102

Group type: EXPERIMENTAL
Intervention: Prenatal exercise (150 min of moderate‐intensity weekly exercise)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Prenatal exercise
Number of subjects: 125

Group type: COMPARATOR
Intervention: Non‐exercising controls (low‐intensity stretching/breathing sessions)
Number of subjects: 125
Study: 35235774

Group type: EXPERIMENTAL
Intervention: Nicotinamide riboside (NR) 1,000 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 34233644

Group type: EXPERIMENTAL
Intervention: Early ultrasound (EUS)
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Smartphone App
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Last Menstrual Period (LMP)
Number of subjects: 325
Study: 34030185

Group type: EXPERIMENTAL
Intervention: Surgical evacuation of the hematoma
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Conservative management (no surgical evacuation)
Number of subjects: 159

Group type: COMPARATOR
Intervention: STICH II surgical cohort
Number of subjects: 159

Group type: COMPARATOR
Intervention: STICH II conservative cohort
Number of subjects: 159

Group type: COMPARATOR
Intervention: MISTIE III surgical cohort
Number of subjects: 159

Group type: COMPARATOR
Intervention: MISTIE III conservative cohort
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Prognostic model using random forest classifier
Number of subjects: 159
Study: 34725039

Group type: EXPERIMENTAL
Intervention: Family-based lifestyle intervention (9 visits and 13 telephone contacts over 1 year)
Number of subjects: 3684

Group type: EXPERIMENTAL
Intervention: Family-based lifestyle intervention
Number of subjects: 3684

Group type: COMPARATOR
Intervention: Control (usual care)
Number of subjects: 3684
Study: 35341156

Group type: EXPERIMENTAL
Intervention: RG group (general treatments combining reduced glutathione)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: CHF group (general treatments combining Chuan Huang Fang)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: RG + CHF group (general treatments combining reduced glutathione and Chuan Huang Fang)
Number of subjects: 162

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 162
Study: 33214162

Group type: EXPERIMENTAL
Intervention: High-definition virtual chromoendoscopy (HDV)
Number of subjects: 188

Group type: COMPARATOR
Intervention: High-definition white light (HDWL)
Number of subjects: 188
Study: 33561357

Group type: EXPERIMENTAL
Intervention: Technology-based auditory training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study: 33136134

Group type: EXPERIMENTAL
Intervention: Oral iron supplements plus 200 mg of vitamin C
Number of subjects: 440

Group type: COMPARATOR
Intervention: Oral iron supplements only
Number of subjects: 440
Study: 36207714

Group type: EXPERIMENTAL
Intervention: CPR
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Endotracheal intubation
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Self-assessed competence and willingness
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Training satisfaction
Number of subjects: 146
Study: 34221029

Group type: EXPERIMENTAL
Intervention: Nursing students
Number of subjects: 580

Group type: EXPERIMENTAL
Intervention: Medical students
Number of subjects: 580

Group type: COMPARATOR
Intervention: Comparison between nursing and medical students
Number of subjects: 580
Study: 34967656

Group type: EXPERIMENTAL
Intervention: Immunosuppressive therapy in addition to conventional heart failure therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional heart failure therapy alone
Number of subjects: 20
Study: 33849606

Group type: EXPERIMENTAL
Intervention: IOERT (10 Gy)
Number of subjects: 245

Group type: COMPARATOR
Intervention: EBRT (5 × 2 Gy)
Number of subjects: 245
Study: 33172465

Group type: EXPERIMENTAL
Intervention: Trigger errors in mechanically ventilated children
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Higher spontaneous breath rate
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Patient-ventilator asynchrony
Number of subjects: 28
Study: 36067336

Group type: EXPERIMENTAL
Intervention: REThink game without guidance
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: REThink game with guidance
Number of subjects: 139

Group type: COMPARATOR
Intervention: Care-as-usual control group
Number of subjects: 139
Study: 35753441

Group type: EXPERIMENTAL
Intervention: Mindful eating programme
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Mindfulness programme
Number of subjects: 284

Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 284
Study: 33984574

Group type: EXPERIMENTAL
Intervention: Sleep group (normal sleep between pretest and posttest)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Wake group (12 hours awake during the day)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Both groups (sleep and wake)
Number of subjects: 89
Study: 32546962

Group type: EXPERIMENTAL
Intervention: FDC of fimasartan 120 mg and atorvastatin 40 mg
Number of subjects: 56

Group type: COMPARATOR
Intervention: Separate tablets of fimasartan and atorvastatin
Number of subjects: 56
Study: 32892246

Group type: EXPERIMENTAL
Intervention: IL BTX‐A
Number of subjects: 50

Group type: COMPARATOR
Intervention: IL 5‐FU
Number of subjects: 50
Study: 34180843

Group type: EXPERIMENTAL
Intervention: Presentation about the futility of antibiotic treatment of URTIs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presentation about the adverse effects associated with antibiotics
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active control (presentation about benefits of healthy diet and exercise)
Number of subjects: 0
Study: 32031887

Group type: EXPERIMENTAL
Intervention: Early integrated palliative and oncology care (PC), with expected monthly meetings with a PC clinician until death.
Number of subjects: 391

Group type: COMPARATOR
Intervention: Usual oncology care, with PC consultations on request.
Number of subjects: 391
Study: 34360028

Group type: EXPERIMENTAL
Intervention: Power Training (PT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ballistic Training (BT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control Group (CON)
Number of subjects: 30
Study: 32349759

Group type: EXPERIMENTAL
Intervention: Pittsburgh Sleep Quality Index (PSQI) > 5
Number of subjects: 4856

Group type: EXPERIMENTAL
Intervention: Pittsburgh Sleep Quality Index (PSQI) > 8
Number of subjects: 4856

Group type: EXPERIMENTAL
Intervention: Average PSQI score
Number of subjects: 4856

Group type: EXPERIMENTAL
Intervention: Tertiary hospitals
Number of subjects: 4856

Group type: EXPERIMENTAL
Intervention: Secondary hospitals
Number of subjects: 4856

Group type: EXPERIMENTAL
Intervention: Primary hospitals
Number of subjects: 4856
Study: 616841197

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Bare metal stents (BMS)
Number of subjects: 47
Study: 36041655

Group type: EXPERIMENTAL
Intervention: Astegolimab 490 mg every 4 weeks for 16 weeks
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 33468118

Group type: EXPERIMENTAL
Intervention: Expository writing (EW)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Argumentative writing (AW)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Self-study (SS)
Number of subjects: 139
Study: 36450458

Group type: EXPERIMENTAL
Intervention: Statin + Ezetimibe (S+E)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Statin (S)
Number of subjects: 79
Study: 33656484

Group type: EXPERIMENTAL
Intervention: Compensatory Cognitive Training (CCT)
Number of subjects: 0
Study: 33631965

Group type: EXPERIMENTAL
Intervention: Dry oxygen
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Dry air
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Humidified oxygen
Number of subjects: 51

Group type: COMPARATOR
Intervention: Humidified air
Number of subjects: 51
Study: 35445840

Group type: EXPERIMENTAL
Intervention: ACTH
Number of subjects: 38

Group type: COMPARATOR
Intervention: Betamethasone
Number of subjects: 38
Study: 34477823

Group type: EXPERIMENTAL
Intervention: Antiplatelet therapy
Number of subjects: 537

Group type: COMPARATOR
Intervention: Avoid antiplatelet therapy (Control)
Number of subjects: 537
Study: 34799682

Group type: EXPERIMENTAL
Intervention: D-Cycloserine (DCS) 50 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HC) 25 mg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 34604426

Group type: EXPERIMENTAL
Intervention: Patellar tendon autograft (PT)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Hamstring tendon autograft (HT)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Both PT and HT groups
Number of subjects: 62
Study: 35486962

Group type: EXPERIMENTAL
Intervention: One-to-one midwifery care
Number of subjects: 7103
Study: 33599684

Group type: EXPERIMENTAL
Intervention: 3DP swab
Number of subjects: 89
Study: 34856181

Group type: EXPERIMENTAL
Intervention: Ivermectin (200 μg/kg) plus Albendazole (400 mg)
Number of subjects: 733

Group type: COMPARATOR
Intervention: Albendazole (400 mg) plus Placebo
Number of subjects: 733
Study: 33435897

Group type: EXPERIMENTAL
Intervention: Piezocision-assisted orthodontics
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control (only extraction)
Number of subjects: 23
Study: 36242052

Group type: EXPERIMENTAL
Intervention: Photography tele‐transmission by ambulance staff
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control group (no photography tele‐transmission)
Number of subjects: 165
Study: 34127635

Group type: EXPERIMENTAL
Intervention: Learning to ride a bicycle
Number of subjects: 62

Group type: COMPARATOR
Intervention: Stationary cycling
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 62
Study: 34532895

Group type: EXPERIMENTAL
Intervention: BUP-NX
Number of subjects: 400

Group type: COMPARATOR
Intervention: XR-NTX
Number of subjects: 400
Study: 33301254

Group type: EXPERIMENTAL
Intervention: Enhanced recovery program after VATS surgery
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Accelerated recovery protocol after open surgery
Number of subjects: 235

Group type: COMPARATOR
Intervention: Traditional management after open surgery
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Enhanced recovery program after open surgery
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: VATS operations
Number of subjects: 235

Group type: COMPARATOR
Intervention: Traditional management
Number of subjects: 235
Study: 35395204

Group type: EXPERIMENTAL
Intervention: gameChange VR therapy plus usual care
Number of subjects: 346

Group type: COMPARATOR
Intervention: usual care alone
Number of subjects: 346
Study: 34127100

Group type: EXPERIMENTAL
Intervention: Combination therapy of Transcranial Magnetic Stimulation (rTMS) with Ketamine (CTK)
Number of subjects: 28
Study: 32460811

Group type: EXPERIMENTAL
Intervention: Assessment of psychosocial distress in doctor-patient conversation
Number of subjects: 616

Group type: COMPARATOR
Intervention: Assessment of psychosocial distress via questionnaire (control, standard of care)
Number of subjects: 616

Group type: EXPERIMENTAL
Intervention: Doctor-patient consultation
Number of subjects: 616
Study: 34774396

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX) continued group
Number of subjects: 159

Group type: COMPARATOR
Intervention: Daily buprenorphine-naloxone (BP-NLX)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Both groups (XR-NTX and BP-NLX)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: High LS group
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Illicit opioid use
Number of subjects: 159
Study: 34096500

Group type: COMPARATOR
Intervention: Enteral feeding during therapeutic hypothermia
Number of subjects: 6030

Group type: COMPARATOR
Intervention: Parenteral nutrition during therapeutic hypothermia
Number of subjects: 6030
Study: 35650663

Group type: EXPERIMENTAL
Intervention: Flipped Classroom (FC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Live Demonstration (LD)
Number of subjects: 40
Study: 34512511

Group type: EXPERIMENTAL
Intervention: Intensive treatment (target SBP 130-140 mmHg)
Number of subjects: 2196

Group type: COMPARATOR
Intervention: Guideline-recommended treatment (SBP <180 mmHg)
Number of subjects: 2196
Study: 35511372

Group type: EXPERIMENTAL
Intervention: Patient-controlled outpatient follow-up on demand
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 33298126

Group type: EXPERIMENTAL
Intervention: Stepped-care approach BETTER CARE
Number of subjects: 540

Group type: COMPARATOR
Intervention: Usual care+
Number of subjects: 540
Study: 35979609

Group type: EXPERIMENTAL
Intervention: 900 mg UDCA for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 0
Study: 32673082

Group type: EXPERIMENTAL
Intervention: Massage alone
Number of subjects: 42

Group type: COMPARATOR
Intervention: Massage plus acupuncture
Number of subjects: 42
Study: 35984934

Group type: EXPERIMENTAL
Intervention: THR device
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: FTCR device
Number of subjects: 16
Study: 33976352

Group type: EXPERIMENTAL
Intervention: Carbon nanoparticle suspension
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 160
Study: 36307193

Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure control (systolic blood pressure <120 mm Hg)
Number of subjects: 14094

Group type: COMPARATOR
Intervention: Standard systolic blood pressure control (systolic blood pressure <140 mm Hg)
Number of subjects: 14094

Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure control
Number of subjects: 14094
Study: 32665041

Group type: EXPERIMENTAL
Intervention: Sudarshan Kriya Yoga (SKY)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Health Enhancement Program (HEP)
Number of subjects: 60
Study: 33601706

Group type: EXPERIMENTAL
Intervention: Next-intended antidepressant (AD) treatment with predicted moderate gene-drug interaction potential
Number of subjects: 1149

Group type: EXPERIMENTAL
Intervention: Next-intended antidepressant (AD) treatment with predicted clinically significant gene-drug interaction potential
Number of subjects: 1149

Group type: EXPERIMENTAL
Intervention: Previous treatment with an antidepressant (AD) in the past two years
Number of subjects: 1149
Study: 33028082

Group type: EXPERIMENTAL
Intervention: MultiPoint pacing with wide anatomic separation (MPP‐AS)
Number of subjects: 506

Group type: COMPARATOR
Intervention: Biventricular single-site pacing
Number of subjects: 506
Study: 35487576

Group type: EXPERIMENTAL
Intervention: CHO + BHB-ME (20 ± 2 g CHO and 590 mg/kg body mass β-hydroxybutyrate monoester)
Number of subjects: 9

Group type: COMPARATOR
Intervention: CHO (90 ± 9 g carbohydrate)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: CHO + BHB-ME
Number of subjects: 9
Study: 33576146

Group type: EXPERIMENTAL
Intervention: 8-week group mindfulness-based cognitive behavioral intervention via videoconference
Number of subjects: 47
Study: 34870387

Group type: EXPERIMENTAL
Intervention: Accommodating variable-resistance exercise (AVr-Ex) program, 3 sessions/week over 8 weeks, in addition to usual physical therapy
Number of subjects: 36
Study: 34187220

Group type: EXPERIMENTAL
Intervention: Accuracy incentives to estimate prognosis
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Framing treatment benefits in terms of loss (mortality)
Number of subjects: 200
Study: 32249696

Group type: EXPERIMENTAL
Intervention: Meditation intervention (90-day training with self-practice)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 136
Study: 35700149

Group type: EXPERIMENTAL
Intervention: Avocado (AV)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control food (C; low fat, low fiber, energy matched)
Number of subjects: 93
Study: 33181415

Group type: EXPERIMENTAL
Intervention: Targeted temperature management (TTM) at 33 °C for either 24 or 48 hours
Number of subjects: 355
Study: 32143733

Group type: EXPERIMENTAL
Intervention: Witnessed oral informed consent (IC) prior to randomization and written IC after percutaneous coronary intervention for ST-segment elevation myocardial infarction patients.
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Witnessed oral informed consent (IC) prior to randomization and written IC before angiography for non-ST-segment elevation myocardial infarction patients.
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: Witnessed oral informed consent (IC) process.
Number of subjects: 414
Study: 35394456

Group type: EXPERIMENTAL
Intervention: NCX 470 0.042%
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: NCX 470 0.065%
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: NCX 470 0.021%
Number of subjects: 433

Group type: COMPARATOR
Intervention: Latanoprost 0.005%
Number of subjects: 433
Study: 33428608

Group type: EXPERIMENTAL
Intervention: Lightwand-guided insertion technique
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard digital manipulation technique
Number of subjects: 54
Study: 32755460

Group type: EXPERIMENTAL
Intervention: Supervised learning algorithms for classifying basal cell carcinoma
Number of subjects: 43794

Group type: EXPERIMENTAL
Intervention: Supervised learning algorithms for classifying squamous cell carcinoma
Number of subjects: 43794

Group type: EXPERIMENTAL
Intervention: Supervised learning algorithms for total counts of specific diagnoses
Number of subjects: 43794

Group type: EXPERIMENTAL
Intervention: Supervised learning algorithms for classifications of keratoacanthoma and intraepidermal carcinoma
Number of subjects: 43794
Study: 36328372

Group type: EXPERIMENTAL
Intervention: Ornidazole 1 g orally 12 hours before surgery
Number of subjects: 926

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 926
Study: 35718979

Group type: EXPERIMENTAL
Intervention: Italian group (10 patients)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Czech group (4 patients)
Number of subjects: 14
Study: 33799055

Group type: EXPERIMENTAL
Intervention: Chatbot intervention (Todaki)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Information-only control (book on managing attention deficit symptoms)
Number of subjects: 46
Study: 35766258

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including bedside delivery of P2Y12 inhibitor, education, automated reminder calls, and outreach for refill delays.
Number of subjects: 1377

Group type: EXPERIMENTAL
Intervention: Multifaceted intervention
Number of subjects: 1377

Group type: COMPARATOR
Intervention: Preintervention control group
Number of subjects: 1377

Group type: COMPARATOR
Intervention: Postintervention control group
Number of subjects: 1377

Group type: COMPARATOR
Intervention: Concurrent control group
Number of subjects: 1377
Study: 34665845

Group type: EXPERIMENTAL
Intervention: Lumbar support with built-in massager system
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no lumbar support)
Number of subjects: 24
Study: 32338063

Group type: EXPERIMENTAL
Intervention: 50 mg DBPR108
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: 100 mg DBPR108
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: 200 mg DBPR108
Number of subjects: 271

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 271
Study: 34126778

Group type: EXPERIMENTAL
Intervention: Getting To Outcomes (GTO) implementation support strategy with RDAD training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual implementation of RDAD without GTO training
Number of subjects: 0
Study: 33404141

Group type: EXPERIMENTAL
Intervention: Incentivised adherence and abstinence monitoring (I-AAM)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 141